13F Filings History of PERCEPTIVE ADVISORS LLC
- Latest 13F filing
- Q2 2026 - 14 Aug 2026
- Latest reported 13F value
- $6,440,507,069
- Largest 13F holdings
-
PRAX SYRE CELC ASND RYTM ROIV RLAY TVTX KARD NUVL EWTX APGE
+8 more
AMLX MGTX ORKA INBX PTGX SLDB ZYME TNGX - Form 13F summary
-
- PERCEPTIVE ADVISORS LLC Form 13F history summarizes parsed U.S.-listed equity disclosures for this manager.
- Form 13F is generally due within 45 days after each calendar quarter ends.
- PERCEPTIVE ADVISORS LLC reported 102 equity holdings with a total reported market value of $6,440,507,069 for Q2 2026. Top reported holdings included PRAX, SYRE, CELC, ASND, and RYTM.
- Manager signature
- Joseph Edelman - Managing Member
- Manager location
- New York, NY
13F snapshot
Latest parsed holdings, value, and filing-period context.
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow PERCEPTIVE ADVISORS LLC with Pro and return when a new 13F portfolio filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
Holdings Value
Form 13F evidence
Quarterly portfolio filings
SEC-reported 13F quarters for this filer, ordered by the latest accepted filing.
Latest quarter
Q2 2026
Latest value
$6,440,507,069
Quarter delta
+$1,377,967,478
Accepted
14 Aug 2026, 16:11
Rows shown
1-25 of 54
| Quarter | Holdings | SEC-reported value | Bought | Sold | Net | Top Holdings | Form Type | Accepted by SEC |
|---|---|---|---|---|---|---|---|---|
| Q2 2026 | 102 | $6,440,507,069 | +$1,422,058,307 | -$1,063,623,896 | +$358,434,411 | PRAX, SYRE, CELC, ASND, RYTM | 13F-HR | 14 Aug 2026, 16:11 |
| Q1 2026 | 92 | $5,062,539,591 | +$742,271,092 | -$1,325,150,143 | -$582,879,051 | PRAX, CELC, ASND, ROIV, CNTA | Restatement | 29 May 2026, 11:41 |
| Q4 2025 | 112 | $5,458,314,260 | +$1,486,457,710 | -$603,090,830 | +$883,366,880 | PRAX, CELC, RYTM, ASND, APGE | 13F-HR | 17 Feb 2026, 16:10 |
| Q3 2025 | 92 | $3,419,009,650 | +$821,104,427 | -$787,596,816 | +$33,507,611 | RYTM, ASND, ACLX, CELC, NUVL | 13F-HR | 14 Nov 2025, 16:10 |
| Q2 2025 | 82 | $2,665,031,775 | +$459,865,368 | -$840,770,074 | -$380,904,706 | VRNA, ASND, ACLX, RYTM, NUVL | 13F-HR | 14 Aug 2025, 16:07 |
| Q1 2025 | 86 | $2,819,733,555 | +$357,093,380 | -$769,139,212 | -$412,045,832 | VRNA, ACLX, FOLD, EWTX, RYTM | Restatement | 06 Aug 2025, 16:10 |
| Q4 2024 | 97 | $3,589,385,681 | +$284,298,925 | -$930,310,339 | -$646,011,414 | VRNA, ACLX, FOLD, RYTM, NUVL | 13F-HR | 14 Feb 2025, 16:09 |
| Q3 2024 | 102 | $4,660,827,140 | +$695,410,645 | -$897,538,739 | -$202,128,094 | ACLX, NUVL, FOLD, IOVA, PCVX | 13F-HR | 14 Nov 2024, 16:10 |
| Q2 2024 | 107 | $4,142,980,796 | +$409,284,558 | -$1,114,847,674 | -$705,563,116 | CERE, FOLD, ACLX, IOVA, NUVL | Restatement | 16 Aug 2024, 16:10 |
| Q1 2024 | 105 | $5,674,407,703 | +$1,462,243,497 | -$627,073,454 | +$835,170,043 | CERE, FOLD, IOVA, ACLX, NUVL | Restatement | 06 Aug 2024, 17:06 |
| Q4 2023 | 97 | $4,473,417,736 | +$884,699,939 | -$393,571,634 | +$491,128,305 | CERE, FOLD, LIANY, ACLX, NUVL | Restatement | 23 Feb 2024, 19:00 |
| Q3 2023 | 87 | $2,974,400,032 | +$385,649,946 | -$544,120,457 | -$158,470,511 | FOLD, CERE, IMVT, ACLX, NUVL | 13F-HR | 14 Nov 2023, 16:14 |
| Q2 2023 | 88 | $3,441,820,169 | +$653,736,275 | -$846,360,384 | -$192,624,109 | FOLD, CERE, LIANY, ACLX, AMLX | Restatement | 24 Aug 2023, 16:10 |
| Q1 2023 | 98 | $3,379,384,054 | +$682,474,085 | -$489,771,793 | +$192,702,292 | FOLD, RETA, AMLX, CERE, MDGL | Restatement | 16 May 2023, 15:29 |
| Q4 2022 | 94 | $3,469,642,456 | +$622,151,330 | -$742,885,711 | -$120,734,381 | FOLD, AMLX, MDGL, CERE, RXDX | 13F-HR | 14 Feb 2023, 16:18 |
| Q3 2022 | 115 | $3,440,420,000 | +$595,474,181 | -$334,042,471 | +$261,431,710 | FOLD, MRTX, CERE, GBT, AMLX | 13F-HR | 14 Nov 2022, 16:24 |
| Q2 2022 | 109 | $2,697,149,000 | +$281,330,791 | -$811,210,779 | -$529,879,988 | FOLD, MRTX, CERE, IOVA, LIANY | 13F-HR | 15 Aug 2022, 16:49 |
| Q1 2022 | 135 | $4,194,632,000 | +$394,184,961 | -$672,270,821 | -$278,085,860 | FOLD, SWTX, LIANY, IOVA, MRTX | 13F-HR | 16 May 2022, 16:31 |
| Q4 2021 | 145 | $5,654,606,000 | $0 | $0 | $0 | MRTX, LIANY, FOLD, SWTX, IOVA | New Holdings | 04 May 2022, 10:18 |
| Q4 2021 | 145 | $5,654,606,000 | +$973,104,018 | -$582,875,674 | +$390,228,344 | MRTX, LIANY, FOLD, SWTX, IOVA | Restatement | 13 Apr 2022, 16:24 |
| Q3 2021 | 138 | $6,038,972,000 | +$585,440,380 | -$875,801,817 | -$290,361,437 | MRTX, BBIO, SWTX, IOVA, FOLD | Restatement | 03 Dec 2021, 15:34 |
| Q2 2021 | 148 | $6,896,932,000 | $0 | $0 | $0 | MRTX, BBIO, SWTX, IOVA, FOLD | New Holdings | 17 Aug 2021, 09:17 |
| Q2 2021 | 148 | $6,896,932,000 | +$965,121,810 | -$605,202,940 | +$359,918,870 | MRTX, BBIO, SWTX, IOVA, FOLD | 13F-HR | 16 Aug 2021, 16:36 |
| Q1 2021 | 136 | $6,724,058,000 | +$917,855,610 | -$1,459,992,096 | -$542,136,486 | MRTX, BBIO, SWTX, IOVA, FOLD | Restatement | 13 Aug 2021, 17:01 |
| Q4 2020 | 137 | $8,494,975,000 | +$2,036,941,845 | -$763,411,404 | +$1,273,530,441 | MRTX, FOLD, BBIO, IOVA, NVTAQ | 13F-HR | 16 Feb 2021, 16:32 |